Global Natamycin Market Overview:
Natamycin is a fungicide which avoids yeasts and moulds from appearing in foods. It is very effective when used in lesser amounts. It is used in small extents as compare to potassium sorbate and unlike other sorbates it prevents yeasts and fungi from migrating into the product, eliminating the cost of reapplication. The action of natamycin does not destroy other bacteria, which means that it does not alter the food natural maturing process. Natamycin is different from other antimicrobial agents as it does not affect the appearance, taste or colour of the products.
- Rising Demand from Food Industry to extend the Shelf Life of Food
- Increasing Consumption of Dairy Product
- Growing Use in Antifungal Pharmaceutical Products
- Use of Artificial Chemical Preservatives as a Substitutes
- New Product Development Using Stabilizing Additives to Improve Stability
- Absence of Reliable Techniques for Developing a Robust
Some of the key players profiled in the report are Danisco (Denmark), Zhejiang Silver-Elephant Bio-engineering Co., Ltd. (China), Lanzhou Weiri (China), Meihua Holdings Group Co., Ltd (China), Chihon Biotechnology (China), VGP Pharmachem (Spain), Beijing Oriental Rada Biotech Co., Ltd. (China), Toku-E Company (United States), D & F Control Systems Inc. (United States) and Avanscure Lifesciences Pvt. Ltd. (India). Analyst at AdvanceMarketAnalytics see Chinese Vendors to retain maximum share of Global Natamycin market by 2024. Considering Market by Packaging, the sub-segment i.e. Plastic Bottle will boost the Natamycin market. Considering Market by Sources, the sub-segment i.e. Plants will boost the Natamycin market.
(EU) 438/2013 of the European Commission, 13 May 2013, modifies and corrects annex II of Regulation (EC) 1333/2008 of the European Parliament and Council with regard to the use of certain food additives. In this Regulation, Natamycin (E 235) is authorised, amongst other additives, in the surface treatment of cold slice and for different food products.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Natamycin market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Natamycin market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Natamycin, Suppliers of Natamycin, Wholesalers, Distributors and Retailers of Natamycin, Healthcare Industry, Food & Beverages Industry, Research Organization and Governmental Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.